State Company for Marketing Drugs and Medical Appliances — KIMADIA
KIMADIA · Iraq · middle east
Iraq's KIMADIA (State Company for Marketing Drugs and Medical Appliances) — the principal national entity for procurement, registration and oversight of medicines and medical devices; leech-specific regulatory pathway has not been independently verified by ASH.
Regulatory Profile
- Agency type
- national regulator
- Region
- middle east
- Country
- Iraq
- Leech status
- unregulated
- Last ASH review
- 2026-05-26
- Website
- https://www.kimadia.iq
Relevant Regulation Codes
- Iraqi Drug Control Law (No. 40 of 1970 and its amendments)
- Iraqi Ministry of Health regulations on medical devices and biomedical products
Prescriber Requirements
- Iraqi Medical Association–registered physician — order required for any biomedical device application
- Allied health professional application under physician supervision per institutional protocol
Supply Chain & GMP
KIMADIA and Ministry of Health registration as applicable; Arabic and English-language labelling. Standard cold-chain conditions; post-conflict reconstruction context may introduce logistical constraints.
Import/Export Rules
KIMADIA and Ministry of Health import authorisation; Ministry of Agriculture / veterinary services clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.
Reimbursement Context
Not covered under public insurance schemes for leech therapy specifically.
ASH Editorial Notes
Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. The Kurdistan Region of Iraq operates parallel health structures under the Kurdistan Regional Government; ASH has not independently mapped how this affects live-organism medical device oversight.
Related Jurisdictions
Israeli MoH — Israel
Israel's Ministry of Health (Misrad HaBri'ut) — leech therapy regulated under the Pharmacists' Ordinance with Medical Devices Division oversight; significant clinical use in reconstructive and microsurgery services.
EDA — Egypt
Egypt's Egyptian Drug Authority (formed 2019, replacing the older CAPA / Central Administration of Pharmaceutical Affairs) — leech therapy regulated as a medical device with parallel traditional-medicine context.
SFDA — Saudi Arabia
Saudi Arabia's SFDA — leech therapy supervised under medical-device pathway, with Saudi Vision 2030 expansion of traditional/complementary medicine via NCCAM-KSA at the Ministry of Health.
MOHAP — United Arab Emirates
UAE Ministry of Health and Prevention — federal authority over health products; leech-specific regulation has not been independently verified by ASH.